Study of Out of Specification for Tisagenlecleucel

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 21, 2019

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell Lymphoma
Interventions
BIOLOGICAL

CTL019

A single intravenous (i.v.) infusion of CAR-positive viable T cells.

Trial Locations (53)

2608677

RECRUITING

Novartis Investigative Site, Chiba

L8V 5C2

COMPLETED

Novartis Investigative Site, Hamilton

K1H 8L6

WITHDRAWN

Novartis Investigative Site, Ottawa

M5G 1X8

COMPLETED

Novartis Investigative Site, Toronto

M5G 2M9

COMPLETED

Novartis Investigative Site, Toronto

H1T 2M4

WITHDRAWN

Novartis Investigative Site, Montreal

G1R 2J6

WITHDRAWN

Novartis Investigative Site, Québec

466 8560

RECRUITING

Novartis Investigative Site, Nagoya

467-8602

RECRUITING

Novartis Investigative Site, Nagoya

791-0295

RECRUITING

Novartis Investigative Site, Tōon

812-8582

RECRUITING

Novartis Investigative Site, Fukuoka

501-1194

RECRUITING

Novartis Investigative Site, Gifu

060 8648

RECRUITING

Novartis Investigative Site, Sapporo

060-8543

RECRUITING

Novartis Investigative Site, Sapporo

650-0047

RECRUITING

Novartis Investigative Site, Kobe

663 8501

RECRUITING

Novartis Investigative Site, Nishinomiya

305-8576

RECRUITING

Novartis Investigative Site, Tsukuba

920 8641

RECRUITING

Novartis Investigative Site, Kanazawa

761-0793

RECRUITING

Novartis Investigative Site, Kita-gun

236-0004

RECRUITING

Novartis Investigative Site, Yokohama

602-8566

RECRUITING

Novartis Investigative Site, Kyoto

514-8507

RECRUITING

Novartis Investigative Site, Tsu

980 8574

RECRUITING

Novartis Investigative Site, Sendai

390-8621

RECRUITING

Novartis Investigative Site, Matsumoto

852-8501

RECRUITING

Novartis Investigative Site, Nagasaki

879-5593

RECRUITING

Novartis Investigative Site, Yufu

710-8602

RECRUITING

Novartis Investigative Site, Kurashiki

700-8558

RECRUITING

Novartis Investigative Site, Okayama

594-1101

RECRUITING

Novartis Investigative Site, Izumi

598-8577

RECRUITING

Novartis Investigative Site, Izumisano

541-8567

RECRUITING

Novartis Investigative Site, Osaka

543-8555

RECRUITING

Novartis Investigative Site, Osaka

589 8511

RECRUITING

Novartis Investigative Site, Ōsaka-sayama

565 0871

RECRUITING

Novartis Investigative Site, Suita

693 8501

RECRUITING

Novartis Investigative Site, Izumo

431-3192

RECRUITING

Novartis Investigative Site, Hamamatsu

113 8655

RECRUITING

Novartis Investigative Site, Bunkyo Ku

113-8431

RECRUITING

Novartis Investigative Site, Bunkyo Ku

113-8677

RECRUITING

Novartis Investigative Site, Bunkyo Ku

113-8519

RECRUITING

Novartis Investigative Site, Bunkyo-ku

104 0045

RECRUITING

Novartis Investigative Site, Chuo Ku

183-8524

RECRUITING

Novartis Investigative Site, Fuchū

105-8471

RECRUITING

Novartis Investigative Site, Minato-ku

157-8535

RECRUITING

Novartis Investigative Site, Setagaya-ku

160 8582

RECRUITING

Novartis Investigative Site, Shinjuku-ku

030 8553

RECRUITING

Novartis Investigative Site, Aomori

734-8551

RECRUITING

Novartis Investigative Site, Hiroshima

860-8556

RECRUITING

Novartis Investigative Site, Kumamoto

606 8507

RECRUITING

Novartis Investigative Site, Kyoto

951 8520

RECRUITING

Novartis Investigative Site, Niigata

545-8586

RECRUITING

Novartis Investigative Site, Osaka

330 8777

RECRUITING

Novartis Investigative Site, Saitama

641-8510

RECRUITING

Novartis Investigative Site, Wakayama

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY